Clinical Application in Ophthalmology passed

Assisted Clinical Application of Gene Therapy in Ophthalmology of Innostellar Accepted by NMPA

Clinical Application for Hemophilia B accepted

Assisted Clinical Application of Gene Therapy for Hemophilia B of Vitalgen Accepted by NMPA

IND application approval

Correcting visual impairment: VGR-R01 project IND application accepted by Center for Drug Evaluation

Completion of series C round funding

uBriGene Biosciences completes several hundred million yuan Series C round funding

20 million USD Series C+ round closed

uBriGene Biosciences Inc. closes 150 million CNY (20 million USD) Series C+ round

Targets North American growth with major acquisition

Cell and Gene Therapy CDMO Targets North American Growth with Major US Acquisition

Mustang Bio transaction completion

uBriGene (Boston) Biosciences completed the transaction with Mustang Bio, Inc. (Nasdaq: MBIO)

Success factors for cell therapy

Top 3 success factors for cell therapy potency assays

Cell Therapy Potency launching

New Service Launch - Cell Therapy Potency Analytical Development and GMP Testing

Educational webinar series by uBriGene

uBriGene's Educational Webinar Series on ATMPs Development and Manufacturing